Product Name
CAS Number
Specification
TP
DMF
Status
Lubiprostone
333963-40-9
In-house
√
Lumateperone Tosylate
1187020-80-9
In-house
Correct
Luseogliflozin Hydrate
898537-18-3
Q4 2025
Q2 2026
Macitentan
441798-33-0
In-house
√
Maralixibat chloride
228113-66-4
In-house
√
Miglitol
72432-03-2
JP, In-house
√
Mirogabalin Besylate
1138245-21-2
Q3 2025
Q1 2026
Nebivolol Hydrochloride
152520-56-4
EP, In-house
√
Nirogacestat hydrobromide
1962925-29-6
Q4 2025
Q2 2026
Olaparib
763113-22-0
In-house
√
Osimertinib mesylate
1421373-66-1
In-house
Q4 2025
Palbociclib
571190-30-2
In-house
√
Pazopanib
444731-52-6
Q1 2026
Q3 2026
Pilocarpine Hydrochloride
54-71-7
USP, EP, JP
√
Plecanatide
467426-54-6
Posaconazole
171228-49-2
In-house
√
Pranlukast
150821-03-7
JP
√
Ramelteon
196597-26-9
In-house
√
Relugolix
737789-87-6
Q4 2025
Q2 2026
Resmetirom
920509-32-6
In-house
Q42025